Abbott Submits NDA For Heat Stable Norvir In Japan
This article was originally published in PharmAsia News
Executive Summary
Abbott Japan submitted a new drug approval application for a heat stable, new tablet formulation of HIV/AIDS drug Norvir (ritonavir) in Japan